OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in HIV and AIDS is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Editorial introductions	113
Integrating socio-behavioral, ethics, community, and translational science considerations in HIV cure research	78
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission	51
The sounds of silencing: dynamic epigenetic control of HIV latency	34
Updates on bone health in people living with HIV: global impact, prediction tools, and treatment	30
Harnessing natural killer cells to target HIV-1 persistence	28
Future options for long-acting HIV treatment and prevention	28
HIV-associated tuberculosis in infants, children, and adolescents younger than 15 years: an update on the epidemiology, diagnosis, prevention, and treatment	27
Impact of early antiretroviral therapy, early life immunity and immune sex differences on HIV disease and posttreatment control in children	26
Statins for primary cardiovascular disease prevention among people with HIV: emergent directions	26
Advancing HIV cure: insights from developing chronic hepatitis b therapies for functional cure	26
Editorial introduction	25
A behavioral economics approach to enhancing HIV preexposure and postexposure prophylaxis implementation	25
Editorial introduction	24
New latency-promoting agents for a block-and-lock functional cure strategy	20
Loneliness and social isolation in people with HIV	20
Fc-mediated immunological mechanisms in HIV infection: a better understanding for improved therapeutic approaches	20
Pulse check: modern strategies for cardiovascular risk in women with detection and prevention in women with HIV	18
Challenges towards an AIDS-free generation in Africa and Asia	18
Editorial introduction	18
Development of screening assays for use of broadly neutralizing antibodies in people with HIV	17
Persistent elite controllers as the key model to identify permanent HIV remission	16
Current insight into HIV-1 persistence from single-cell transcriptome profiling in acutely treated cohorts of infection	14
The origins of new SARS-COV-2 variants in immunocompromised individuals	14
Balancing polypharmacy and comorbidity management: cardiovascular health	14

Integrating substance use services into HIV care: an underused implementation science opportunity	13
Editorial introduction	13
Viral and immune predictors of HIV posttreatment control	13
New vector and vaccine platforms: mRNA, DNA, viral vectors	13
Role of follicular homing natural killer cells in HIV infection	13
Impact of coronavirus disease 2019 on co-morbidities in HIV	13
Defining multimorbidity in people with HIV – what matters most?	13
Mpox and the impact on people with HIV	12
The multifaceted nature of HIV tissue reservoirs	12
Hepatitis co-infection in paediatric HIV: progressing treatment and prevention	12
Aging of adult lifetime survivors with perinatal HIV	12
Obesity among women with HIV	11
Gender and sex considerations in HIV and bone health	11
Broadly neutralizing antibodies for HIV treatment and cure approaches	11
Metabolic dysfunction-associated steatotic liver disease in people with HIV	11
Single-cell multiomic understanding of HIV-1 reservoir at epigenetic, transcriptional, and protein levels	11
Frailty in people with HIV: a geriatric syndrome approach to aging with HIV	11
Single-cell sequencing technologies: a multiomics toolbox for investigating HIV-1 persistence	10
Editorial: New drugs for HIV: quo vadis?	10
Roadmap for spatial transcriptomics of HIV in tissues	10
Beyond criminalization: reconsidering HIV criminalization in an era of reform	10
Host factors predisposing to kidney disease in people with HIV	10
Maintain the gains: methods to evaluate the sustainability and scalability of HIV-related prevention, care, and treatment programs	9
The severity of COVID-19 across the spectrum of HIV	9
Use of implementation theories, models, and frameworks in PrEP implementation research from 2022–2025: innovation and participation	9
Strategies to target the central nervous system HIV reservoir	8
Harnessing innate immunity: natural killer cells and innate immune responses in reservoir clearance	8
Innovative models of care supporting people aging with HIV	8
HIV and cardiovascular disease: the role of inflammation	8
Editorial introduction	8
Editorial introductions	8
Causes and outcomes of hepatic fibrosis in persons living with HIV	7
Editorial: Is it time to implement injectable antiretroviral treatments globally?	7
Persistent HIV-1 transcription during ART: time to reassess its significance?	7
Contemporary issues in gynecologic and reproductive health for women with HIV	7
The pathogenesis of obesity in people living with HIV	7
HIV drug resistance in various body compartments	7
Vaccinal effect of HIV-1 antibody therapy: dream or reality?	7
CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies	7
Editorial introduction	6
Guiding HIV-1 vaccine development with preclinical nonhuman primate research	6
How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?	6
HIV-1 subtypes and latent reservoirs	6
The role of analytical treatment interruptions in shaping HIV-specific immunity and HIV cure	6
Adolescents and young adults with HIV and unsuppressed viral load: where do we go from here?	6
Editorial introductions	6
Editorial introductions	6
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development	6
Role of islatravir in HIV treatment and prevention: an update	5
HIV and comorbidities – the importance of gut inflammation and the kynurenine pathway	5

Towards a molecular profile of antiretroviral therapy-free HIV remission	5
Whole person HIV services: a social science approach	5
The innovative use of qualitative and mixed methods research to advance improvements along the HIV prevention and care continua	5
Editorial introductions	5
Stem cell transplantation and allogeneic immunity: post treatment control or HIV cure?	5
Towards an HIV cure: one cell at a time	5
Care of people aging with HIV in resource limited settings	5
Key population perceptions and opinions about long-acting antiretrovirals for prevention and treatment: a scoping review	5
Editorial: HIV and cardiovascular disease: recognizing and reducing disparities	4
Cardiovascular disease risk in women living with HIV	4
Promoting patient-centered care within HIV care settings in sub-Saharan Africa	4
Editorial introductions	4
Editorial introductions	4
Epidemiology of HIV drug resistance in low- and middle-income countries and WHO global strategy to monitor its emergence	4
Scaling up preexposure prophylaxis to maximize HIV prevention impact	4
Human papillomavirus infection among adolescents living with HIV: a focus on prevention	4
Cognitive impairment in persons with HIV: changing aetiologies and management strategies	4
Humanized mice for studying HIV latency and potentially its eradication	4
Single cell analyses of the HIV reservoir in the CNS and CSF: recent insights and implications	4
Safety of oral tenofovir disoproxil - emtricitabine for HIV preexposure prophylaxis in adults	4
Delivery platforms for broadly neutralizing antibodies	3
The predictive value of macaque models of preexposure prophylaxis for HIV prevention	3
Immune checkpoint inhibition as a therapeutic strategy for HIV eradication: current insights and future directions	3
Divide and conquer: broadly neutralizing antibody combinations for improved HIV-1 viral coverage	3
Age at ART initiation and proviral reservoir size in perinatal HIV-1 infection: considerations for ART-free remission	3
The state of the art of adaptation strategies for HIV-related interventions	3
Editorial introduction	3
Recent data on the role of antiretroviral therapy in weight gain and obesity in persons living with HIV	3
Zika virus: an overview update	3
Using single cell technologies to understand HIV latency models	3
It's all in the gut: the central role of the gut and microbiome in preventing disease progression in simian immunodeficiency viruses infected African nonhuman primates	3
The power of ten in HIV remission: insights from hematopoietic stem cell transplantation	3
The female microbiome in HIV prevention, pathogenesis, and treatment	3
Monocytes across life span in HIV infection: lights and shadows	3
Pediatric immunotherapy and HIV control	3
Editorial introduction	3
Targeting HIV myeloid and central nervous system reservoirs for HIV cure	3
Utilizing immunotherapy towards achieving a functional cure for HIV-1	2
A world of choices: preference elicitation methods for improving the delivery and uptake of HIV prevention and treatment	2
The vaginal microbiome and HIV transmission dynamics	2
HIV T-cell immunogen design and delivery	2
Understanding residual risk of cardiovascular disease in people with HIV	2
Humoral immunity in HIV-1 post-treatment controllers	2
Public health services and intersectional stigma: a social sciences perspective with implications for HIV service design and delivery	2
Ending the HIV epidemic for all, not just some: structural racism as a fundamental but overlooked social-structural determinant of the US HIV epidemic	2
Human models that inform antiretroviral therapy-free remission with perinatally acquired HIV infection	2
Implementation of long-acting antiretroviral therapy in low-income and middle-income countries	2
Pulmonary comorbidities in people with HIV− the microbiome connection	2
Post-intervention control in HIV immunotherapy trials	2
Editorial introductions	2
Technologies for HIV-1 drug resistance testing: inventory and needs	2
Promises and challenges: cabotegravir for preexposure prophylaxis	2
Editorial introductions	2
Geriatric syndromes in women living with HIV	2
Features of functional and dysfunctional CD8+ T cells to guide HIV vaccine development	2
The future of long-acting agents for preexposure prophylaxis	2
Advancing considerations of context in the evaluation and implementation of evidence-based biomedical HIV prevention interventions: a review of recent research	2
Management of pain and other palliative needs in older people with HIV	2
HIV and obesity: updates in management strategies	2
Transforming HIV prevention: the promise of long-acting preexposure prophylaxis in high HIV burden settings	2
Modeling the fallout: projecting the global impact of donor funding cuts on HIV prevention, treatment, and care	2
Immune signatures and biomarkers of viral control in early-treated children with HIV: insights informing intervention	2
Stepping stones to cure in children with HIV	2